Quadruple combination therapy with SGLT2i, GLP-1RA, ARNI and MRA in heart failure with preserved ejection fraction patients with type 2 diabetes mellitus: A prospective and observational cohort study
Quadruple combination therapy with SGLT2i, GLP-1RA, ARNI, and MRA in HFpEF patients with T2DM was associated with favorable clinical outcomes, especially in participants with LVEF less than 60%.
Authors
- Jiahan Ke (ORCID: https://orcid.org/0009-0007-1573-3169)
- Huasu Zeng (ORCID: https://orcid.org/0009-0006-2714-9229)
- Min Wang (ORCID: https://orcid.org/0000-0002-6495-5637)
- Junfeng Zhang (ORCID: https://orcid.org/0000-0002-9557-0326)
- Kan Chen (ORCID: https://orcid.org/0000-0003-4429-9043)
- Changqian Wang (ORCID: https://orcid.org/0000-0002-5828-657X)
- Jun Gu (ORCID: https://orcid.org/0000-0003-0999-864X)
- Xiaohan Qiu (ORCID: https://orcid.org/0009-0005-3737-7981)
Institutions
- Shanghai Ninth People's Hospital (CN)
Publication Details
- Journal
- Kardiologia Polska
- Published
- 2025-12-03
- DOI
- https://doi.org/10.33963/v.phj.109920
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Shanghai Municipal Health Commission
- National Natural Science Foundation of China
- Science and Technology Commission of Shanghai Municipality